Selected pro-inflammatory cytokines, bone metabolism, osteoprotegerin, and receptor activator of nuclear factor-κB ligand in girls with anorexia nervosa

被引:23
|
作者
Ostrowska, Zofia [1 ]
Ziora, Katarzyna [2 ]
Oswiecimska, Joanna [2 ]
Marek, Bogdan [3 ]
Swietochowska, Elzbieta [1 ]
Kajdaniuk, Dariusz [3 ]
Strzelczyk, Joanna [1 ]
Cieslicka, Anna [1 ]
Wolkowska-Pokrywa, Kinga [1 ]
Kos-Kudla, Beata [4 ]
机构
[1] Silesian Med Univ, Sch Med, Div Dent Zabrze, Dept Med & Mol Biol, Katowice, Poland
[2] Silesian Med Univ, Sch Med, Div Dent Zabrze, Dept Paediat, Katowice, Poland
[3] Silesian Med Univ, Sch Med, Div Dent Zabrze, Dept Pathophysiol & Endocrinol,Div Pathophysiol, Katowice, Poland
[4] Silesian Med Univ, Sch Med, Div Dent Zabrze, Dept Pathophysiol & Endocrinol,Div Clin Endocrino, Katowice, Poland
关键词
anorexia nervosa; girls; pro-inflammatory cytokines; bone metabolism; OPG; sRANKL; NECROSIS-FACTOR-ALPHA; ADOLESCENT GIRLS; RANKL/RANK/OPG SYSTEM; PLASMA-CONCENTRATIONS; FEMALE ADOLESCENTS; SECRETORY DYNAMICS; MINERAL DENSITY; GROWTH-HORMONE; ADIPOSE-TISSUE; LEPTIN LEVELS;
D O I
10.5603/EP.2015.0040
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: It has been indicated that disturbances in the production of certain pro-inflammatory cytokines might contribute to the development of osteoporosis in girls with anorexia nervosa (AN). The aim of the study was to determine whether girls with AN exhibited a relationship between IL-1 beta, IL-6, TNF-alpha, bone turnover markers (OC and CTx), OPG, sRANKL, and the OPG/sRANKL ratio. Material and methods: Serum IL-1 beta, IL-6, TNF-alpha, OC, CTx, OPG, and sRANKL were determined by ELISA in 59 girls with AN and in 17 healthy counterparts, aged 13 to 17 years. Results: Girls with AN showed significant reduction in body weight, BMI, BMI-SDS, and Cole index compared to the controls. These changes were associated with a significant increase in IL-1 beta, IL-6, TNF-alpha, OPG, and sRANKL concentrations and a decrease in bone markers and the OPG/sRANKL ratio. Significant negative correlations were found between BMI, the Cole index and CTx, OPG (girls with AN); between BMI and OC, CTx as well as the Cole index and CTx (the control group - C); between BMI, the Cole index and IL-beta 1, IL-6, TNF-alpha, CTx in all study participants (group AN+C). The combined group AN+C also exhibited positive correlation between BMI, the Cole index, and the OPG/sRANKL ratio. Girls with AN showed positive correlations between IL-1 beta, IL-6, and CTx as well as between TNF-alpha and sRANKL whereas the correlation between TNF-alpha and the OPG/sRANKL ratio was negative (IL-6 and IL-1 beta were identified to be independent predictors of CTx, TNF-alpha and IL-6 independently predicted sRANKL while TNF-alpha, IL-6, and IL-1 beta were independent predictors of the OPG/sRANKL ratio). The control participants exhibited negative correlations between IL-1 beta and OPG and positive correlations between IL-1 beta and sRANKL (IL-1 beta was found to be an independent predictor of OPG and sRANKL). In the AN+C group, IL-1 beta correlated negatively with OC and OPG and positively with sRANKL, while IL-6 and TNF-alpha positively correlated with CTx (IL-6 and TNF-alpha turned out to be independent predictors of CTx, IL-1 beta of OPG while IL-6, TNF-alpha, and IL-1 beta were independent predictors of sRANKL and the OPG/sRANKL ratio). Conclusions: The relationship between the nutritional status and IL-1 beta, IL-6, and TNF-alpha concentrations as well as bone status indicators seems to indicate that abnormalities observed regarding the concentrations of pro-inflammatory cytokines and bone remodelling in girls with AN might result from malnutrition. Correlations between IL-1 beta, IL-6, TNF-alpha, bone markers, OPG, its ligand sRANKL, and/or the OPG/sRANKL ratio suggest potential involvement of these cytokines in the mechanism underlying the lack of the expected bone mineral density increase in adolescent girls.
引用
收藏
页码:313 / 321
页数:9
相关论文
共 50 条
  • [1] Bone metabolism, osteoprotegerin, receptor activator of nuclear factor-κB ligand and selected adipose tissue hormones in girls with anorexia nervosa
    Ostrowska, Zofia
    Ziora, Katarzyna
    Oswiecimska, Joanna
    Swietochowska, Elzbieta
    Marek, Bogdan
    Kajdaniuk, Dariusz
    Wolkowska-Pokrywa, Kinga
    Kos-Kudla, Beata
    ENDOKRYNOLOGIA POLSKA, 2014, 65 (01) : 33 - 39
  • [2] TGF-β1, bone metabolism, osteoprotegerin, and soluble receptor activator of nuclear factor-κB ligand in girls with anorexia nervosa
    Ostrowska, Zofia
    Ziora, Katarzyna
    Oswiecimska, Joanna
    Swietochowska, Elzbieta
    Marek, Bogdan
    Kajdaniuk, Dariusz
    Strzelczyk, Joanna
    Golabek, Karolina
    Wolkowska-Pokrywa, Kinga
    Kos-Kudla, Beata
    ENDOKRYNOLOGIA POLSKA, 2016, 67 (05) : 493 - 500
  • [3] Selected adipose tissue hormones, bone metabolism, osteoprotegerin and receptor activator of nuclear factor-κB ligand in postmenopausal obese women
    Ostrowska, Zofia
    Swietochowska, Elzbieta
    Marek, Bogdan
    Kajdaniuk, Dariusz
    Tyrpien-Golder, Krystyna
    Wolkowska-Pokrywa, Kinga
    Damasiewicz-Bodzek, Aleksandra
    Kos-Kudla, Beata
    ENDOKRYNOLOGIA POLSKA, 2014, 65 (06) : 438 - 448
  • [4] Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biology
    Lorenz C. Hofbauer
    Armin E. Heufelder
    Journal of Molecular Medicine, 2001, 79 : 243 - 253
  • [5] Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biology
    Hofbauer, LC
    Heufelder, AE
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2001, 79 (5-6): : 243 - 253
  • [6] Osteoprotegerin, receptor activator of nuclear factor κB and receptor activator of nuclear factor κB ligand and bone mineralization in children with inflammatory bowel diseases
    Jankowska, Agnieszka
    Korzon-Burakowska, Anna
    Kaminska, Barbara
    PRZEGLAD GASTROENTEROLOGICZNY, 2011, 6 (04): : 213 - 217
  • [7] Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss
    Trouvin, Anne-Priscille
    Goeb, Vincent
    CLINICAL INTERVENTIONS IN AGING, 2010, 5 : 345 - 354
  • [8] Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues
    Liu, Wei
    Zhang, Xianlong
    MOLECULAR MEDICINE REPORTS, 2015, 11 (05) : 3212 - 3218
  • [9] The role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases
    Hofbauer, LC
    Heufelder, AE
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (07): : 2355 - 2363
  • [10] The Effect of Osteoprotegerin (OPG)/Receptor Activator of Nuclear Factor-κB Ligand (RANKL)/Receptor Activator of Nuclear Factor-κB (RANK) on Aortic Valve Calcified
    Luo, Wei
    Wang, Jing
    Yang, Xia
    Li, Junshan
    Song, Yanqiu
    Cong, Hongliang
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2024, 54 (05): : 633 - 642